Migraine without Aura: Clinical Trials

109 trials for Migraine without Aura, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

67 completed, 15 unknown, 8 recruiting, 6 terminated. 51 Not applicable, 16 Phase 3, 11 Phase 2, 10 Phase 4, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable51Completed 33, Unknown 4, Not yet recruiting 3, Recruiting 3, Withdrawn 3, Enrolling by invitation 2, Terminated 2, Active not recruiting 1
Phase 316Completed 13, Unknown 2, Terminated 1
Phase 211Completed 8, Recruiting 1, Terminated 1, Unknown 1
Phase 410Completed 5, Terminated 2, Unknown 2, Suspended 1
Phase 15Completed 3, Not yet recruiting 1, Recruiting 1

Follow Migraine without Aura: new trials by email Literature Review of Migraine without Aura trials Research Report on Migraine without Aura

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using Virtual Reality to Teach Mindfulness to People With Migraine
ACT therapy delivered by REACT NeuroVR headset - Migraine Disorders, Migraine With Aura
Not applicableNot yet recruitingBrigham and Women's Hospital1602026-09-302026-09-30
A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department
Rimegepant, Zavegepant - Migraine, Migraine Disease
Phase 1RecruitingUniversity of South Florida1002026-09-152026-10-27
Study of EVO756 in Adults With Migraine
EVO756, Dose 1, EVO756, Dose 2, Placebo - Migraine
Phase 2RecruitingEvommune, Inc.3302026-07-292026-10-02
A Comprehensive Digital Care Program for Migraine Management
Neuromodulation Wearable Device, Migraine Digital Care Program - Migraine, Migraine With Aura
Not applicableEnrolling by invitationHinge Health, Inc1402026-07-092026-09-17
Preventive Role of Melatonin and Propranolol Administration in Pediatric Migraine
Melatonin, Propranolol - Migraine Disorders
Not applicableEnrolling by invitationNishtar Medical University602026-06-102026-08-03
App-Based Migraine Treatment: The Health enSuite Study
Health enSuite Headache - Migraine, Migraine With Aura
Not applicableNot yet recruitingIWK Health Centre4152026-02-152026-01-27
Myotensive Extraocular Muscle Techniques Added to Manual Therapy for Migraine Without Aura
Myotensive Extraocular Muscle Techniques + Manual Therapy, Standard Manual Therapy - Migraine Without Aura
Not applicableNot yet recruitingFacultad de Enfermería, Fisioterapia y Podología (FEFP)842026-01-082025-11-28
Efficacy and Mechanism of Fu's Subcutaneous Needling Treatment for Migraine Without Aura
Fu's Subcutaneous Needling, Flunarizine Hydrochloride - Migraine Without Aura
Phase 1Not yet recruitingGuangzhou University of Chinese Medicine602025-09-012025-07-16
Healthy Living Partnerships for Veterans With Migraine
Intensive Lifestyle Intervention - Migraine, Migraine Disorders
Not applicableWithdrawnWake Forest University Health Sciences2025-06-012025-07-02
Management of Acute Tinnitus With Migraine Medications
Nortriptyline, Topiramate, Paroxetine - Tinnitus
Phase 4SuspendedUniversity of California, Irvine1002025-06-012026-10-27
Trial Designs for Evaluating Migraine Treatment
Active drug for acute migraine treatment, Placebo Oral Tablet - Migraine With Aura, Migraine Without Aura
Not applicableRecruitingUniversity of Aarhus1282024-11-132026-04-13
BE WELL With Migraine: Brain Education and WELLness With Migraine
Brain Education and WELLness with Migraine Group A, Brain Education and WELLness with Migraine Group B - Migraine
Not applicableRecruitingWake Forest University Health Sciences2862024-07-312026-06-12
Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients
Atogepant 60 mg - Migraine, Migraine With Aura
Active not recruitingUniversity of Florence5002024-05-092026-01-21
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Rimegepant 75 mg - Migraine, Migraine With Aura
RecruitingUniversity of Florence1002024-03-262026-06-11
Effectiveness and Tolerability of Eptinezumab
Eptinezumab 100 or 300 mg ev - Migraine, Migraine With Aura
CompletedUniversity of Florence1302024-03-262026-06-11
Mi-Helper Transnasal Cooling for Acute Treatment of Migraine
Mi-Helper - Episodic Migraine, Migraine With Aura
Not applicableCompletedCoolTech LLC1722023-11-152024-09-26
Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine
Anisodine Hydrobromide, Anisodine Hydrobromide placebo - Migraine Without Aura, Migraine With Aura
Phase 3UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine2882023-10-302024-02-28
Migraine Attack Pain Phase Prediction Study
Migraine, Migraine Headache
Active not recruitingFundación de Investigación Biomédica - Hospital Universitario de La Princesa702023-10-092026-09-23
Responding With Evidence and Access for Childhood Headaches
CBT, Amitriptyline - Headache, Headache Disorders
Not applicableRecruitingChildren's Hospital Medical Center, Cincinnati4002023-08-222026-09-21
Migraine With and Without Aura Characteristics and Response to Remote Electrical Neuromodulation (REN) Treatment
Nerivio device - Migraine With Aura, Migraine Without Aura
CompletedTheranica317152023-07-012025-08-15

Showing 20 of 109. Sign in to see all of them.

Narrower conditions

Migraine with Aura (74)  ·  Migraine Disorders (67)  ·  Headache (22)  ·  Pain (8)  ·  Headache Disorders (7)  ·  Headache Disorders, Secondary (5)  ·  Headache Disorders, Primary (3)  ·  Brain Diseases (2)  ·  Emergencies (2)  ·  Tension-Type Headache (2)  ·  Agnosia (1)  ·  Aneurysm (1)  ·  Behavior (1)  ·  Central Nervous System Diseases (1)

Broader conditions

Central Nervous System Diseases (108)  ·  Nervous System Diseases (108)  ·  Brain Diseases (107)  ·  Headache Disorders, Primary (106)  ·  Headache Disorders (102)  ·  Migraine Disorders (42)  ·  Pathological Conditions, Signs and Symptoms (30)  ·  Signs and Symptoms (28)  ·  Neurologic Manifestations (27)  ·  Pain (16)  ·  Pathologic Processes (3)  ·  Sensation Disorders (3)  ·  Cardiovascular Diseases (2)  ·  Disease Attributes (2)  ·  Vascular Diseases (2)

Interventions

Topiramate (6)  ·  Dihydroergotamine (5)  ·  Pituitary Adenylate Cyclase-Activating Polypeptide (5)  ·  Cromakalim (4)  ·  rimegepant sulfate (4)  ·  Metoclopramide (3)  ·  Propranolol (3)  ·  Sodium Chloride (3)  ·  Sumatriptan (3)  ·  Acupuncture Therapy (2)  ·  Botulinum Toxins, Type A (2)  ·  Cilostazol (2)  ·  Flunarizine (2)  ·  Nitroglycerin (2)  ·  almotriptan (2)

Sponsors

Danish Headache Center (18)  ·  Satsuma Pharmaceuticals, Inc. (5)  ·  University of Florence (5)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3)  ·  Wake Forest University Health Sciences (3)  ·  Children's Hospital Medical Center, Cincinnati (2)  ·  CoolTech LLC (2)  ·  Glostrup University Hospital, Copenhagen (2)  ·  Kocaeli University (2)  ·  Minster Research Ltd (2)  ·  Norwegian University of Science and Technology (2)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  Swedish Medical Center (2)  ·  Theranica (2)  ·  Vastra Gotaland Region (2)

Countries

United States (31)  ·  Denmark (24)  ·  China (7)  ·  Italy (7)  ·  Turkey (Türkiye) (7)  ·  France (5)  ·  Spain (5)  ·  Norway (4)  ·  Canada (3)  ·  Sweden (3)  ·  Hungary (2)  ·  Israel (2)  ·  Netherlands (2)  ·  United Kingdom (2)  ·  Austria (1)

Top investigators

Messoud Ashina, Prof. (4)  ·  Detlef Albrecht, MD (3)  ·  Kaiming Liu, MD & PHD (2)  ·  Rebecca E Wells, MD, MPH (2)  ·  Scott Powers, PhD (2)  ·  Alit Stark Inbar, PhD (1)  ·  Ana Beatriz Gago Veiga (1)  ·  Angel L Guerrero Peral, MD, PhD (1)  ·  Annette C Toledano, M.D. (1)  ·  Bradley J Katz, MD (1)  ·  Chuanlong Zhou (1)

Results publications

PMID 22590713, PMID 23731663, PMID 24524844, PMID 30353868, PMID 30496104, PMID 30879893, PMID 32430657, PMID 11112243, PMID 14982912, PMID 15096395, PMID 15316798, PMID 16135345, PMID 17175134, PMID 18662331, PMID 19222510, PMID 19453963, PMID 20548058, PMID 20974598, PMID 22520687, PMID 23946318, PMID 24030685, PMID 24171782, PMID 24335848, PMID 25744676, PMID 26134103, PMID 26145718, PMID 26603732, PMID 27154997, PMID 27696633, PMID 28241154, PMID 28322750, PMID 28324697, PMID 29310498, PMID 30310310, PMID 31074005, PMID 31104505, PMID 31331265, PMID 31985049, PMID 32213509, PMID 33050719, PMID 33315046, PMID 33567890, PMID 34418951, PMID 34431322, PMID 35957963, PMID 38181724, PMID 38413540, PMID 38850034, PMID 39373843, PMID 39762740

NIH funding

2008 (1), 2014 (1), K23AT008406 (1), R01AT011502 (1), U01AT010132 (1), UL1TR001420 (1)